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M IS-C Em er gen cy Depar t m en t Algor it h m
Initial Evaluation and Treatment of
Multisystem Inflammatory Syndrome in
Children (MIS-C)

In clu sion Cr it er ia:
- Patients <21 yo presenting with Fever ? 38°C AND
- ? 2 of the following organ systems involved:
- Cardiac
- Renal
- Pulmonary
- Hematology
- GI: pain, V/D, anorexia, loss of taste
- Derm: Rash, Oral mucosal changes
- Neuro: Headache/irritability/lethargy/AMS
OR
- One or more of the following:
- Shock (compensated or hypotensive)
- Evidence of cardiac dysfunction
- End organ involvement
OR
- Features of complete or incomplete Kawasaki Disease
Exclu sion Cr it er ia:
- Alternative plausible diagnosis

Evaluation for Possible MIS-C

Initial Assessment:
- History and Physical exam
- Assess for history of COVID-19
exposure within last 4 - 6 weeks OR
- Current or previous positive COVID-19
PCR, serology, or antigen test
- Assess for sepsis/shock
- Sepsis Crawler alert

Com pen sat ed sh ock :
persistent tachycardia
despite antipyretics, BP
may be normal or have
wide pulse pressure,
intact peripheral
perfusion or brisk cap
refill
Hypot en sive sh ock :
tachycardia, hypotension
and/or wide pulse
pressure, delayed or
flash peripheral perfusion
* Provider discretion
should be used when
initiating MIS-C workup,
determining low versus
high suspicion and patient
disposition.

Does the pt have
either compensated or
hypotensive shock?

Yes

Suspect MIS-C with Compensated or Hypotensive Shock
- Fever/history of fever ? 38.0 °C for ? 1 day PLUS meets
inclusion criteria

No
Suspect MIS-C without Shock
- Fever/history of fever ? 38.0 °C for ? 3 days PLUS meets
inclusion criteria
- OR Provider Discretion*

In it iat e EDP MIS-C Pow er plan
* For low suspicion of MIS-C start with tier 1 labs progress to tier 2 labs if lab
results increase suspicion or patient ill appearing/high suspicion of MIS-C
Tier 1 Labs:
CBC, BMP, LFTs, CRP, ESR, Blood Cx Other testing as clinically indicated for
fever workup (UA/Urine Cx)
Tier 2 Labs:
Troponin, NT-proBNP, ECG, D-dimer, Ferritin, Fibrinogen, CPK, PT, PTT, INR,
LDH, Lactate, VBG, Triglycerides, UA, COVID-19 PCR

* Considered admission for further
observation while completing the
diagnostic evaluation, especially if the
pt. displays any of the following:
- Abnormal vital signs (tachycardia,
tachypnea)
- Respiratory distress of any severity
- Neurologic deficits or change in
mental status (including subtle
manifestations)
- Evidence of even mild renal or
hepatic injury
- Markedly elevated inflammatory
markers
- Abnormal EKG, NT-proBNP, or
troponin
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Yes

- Initiate EDP Sepsis or Sepsis Inpatient
and EDP MIS-C powerplans
- Obtain Istat VBG
- Send Tier 1 and Tier 2 labs
- Antibiotics per Sepsis powerplan
- Obtain ECG, CXR, and ECHO
- Frequently reassess after fluids to
avoid fluid overload

Admit to PICU

Are labs
and physical exam
reassuring?*

Yes

No

Are labs
concerning and/or is pt.
ill appearing?*

Yes

Does the pt have
any evidence of shock or
cardiac dysfunction?

Yes

Should the
pt. be admitted to
PICU?

No
No
Discharge home with:
- PCP follow up in 24-48 hrs
OR
- Return to ED for fever ? 5 days
and/or new signs/symptoms

No

Admit pt. to Medical Unit
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This care process model/clinical practice guideline is meant as a guide for the healthcare provider, does not establish a standard of care, and is not a substitute for medical judgment
which should be applied based upon the individual circumstances and clinical condition of the patient.

